Medical device operating metrics
How we read this →Every figure below is for Q1 2026.
| Company | BSXBoston Scientific Corp. | MDTMedtronic plc | SYKStryker Corp. | ZBHZimmer Biomet Holdings, Inc. |
|---|---|---|---|---|
| Price | $43.13 | $90.87 | $269.26 | $92.56 |
| Enterprise value | $74.5B | |||
| Market cap | $64.1B | $17.9B | ||
| LTM revenue | $21.0B | $36.4B | $25.8B | $8.5B |
| LTM net income | $3.7B | $4.8B | $3.7B | $806.7M |
| Reported period | Q1 2026 | Q4 2026ended Apr 24, 2026 | Q1 2026 | Q1 2026 |
| Segment revenue | $5.20B | $9.81B | $6.02B | $2.09B |
Context columns: share price and market value are from the latest recorded exchange data; LTM figures sum the issuer's last four quarterly filings and render blank unless all four quarters are on file; enterprise value = market value + total debt − cash from the latest quarterly balance sheet. These columns are sized context, not part of the SEC-exhibit extraction the table below is built from.
Metric coverage
- Segment revenue: 4 of 4 companies report this on the canonical basis.
Oxford Ledge Signal -- extracted from the issuer's own SEC earnings exhibit and normalized by Oxford Ledge. As reported by the issuer per regulatory convention, not re-audited by us; a figure our extractor could not verify is withheld, never shown. A metric is compared only across companies reporting it on the SAME basis and scope; a blank cell is an honest coverage gap, never a zero, and companies may report different quarters (see the period range). Source: each issuer’s own SEC EDGAR earnings exhibit.